Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Exploring the predictive value of the evoked potentials score in MS within an appropriate patient population: a hint for an early identification of benign MS?
Gait termination in individuals with multiple sclerosis.
Anthocyanins suppress the secretion of proinflammatory mediators and oxidative stress, and restore ion pump activities in demyelination.
Fatigue in patients with multiple sclerosis: is it related to pro- and anti-inflammatory cytokines?
Neurology issues in schizophrenia.
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.
Recall strategies for the verbal fluency test in patients with multiple sclerosis.
Aryl hydrocarbon receptor-mediated induction of the microRNA-132/212 cluster promotes interleukin-17-producing T-helper cell differentiation.
Putative association of GPC5 polymorphism with the risk of inflammatory demyelinating diseases.
Remote control-triggering of brain autoimmune disease in the gut.
Clinical features of patients with Guillain-Barré syndrome at seven hospitals on the East Coast of Australia.
Multiple sclerosis in 2013: Novel triggers, treatment targets and brain atrophy measures.
Treatment of Experimental Autoimmune Encephalomyelitis by Co-Delivery of Disease Associated Peptide and Dexamethasone in Acetalated Dextran Microparticles.
Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis.
Correction: multiple sclerosis in the mount etna region: possible role of volcanogenic trace elements.
Functional clinical outcomes in multiple sclerosis: Current status and future prospects.
Amyotrophic lateral sclerosis and multiple sclerosis overlap: a case report.
Intractable Vomiting Antecedent to Optic Neuritis: An Early Clinical Clue to Neuromyelitis Optica.
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis.
Commentary on 'Disability outcome measures in multiple sclerosis clinical trials'
Disconnection of the hippocampus and amygdala associated with lesion load in relapsing-remitting multiple sclerosis: a structural and functional connectivity study.
Chronic hepatitis B infection presenting with chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): a case report.
Prevalence of multiple sclerosis in Brazil: A systematic review.
The interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: concept, content, and pilot results.
MicroRNAs and multiple sclerosis: from physiopathology toward therapy.
Pages
« first
‹ previous
…
494
495
496
497
498
499
500
501
502
…
next ›
last »